Bone mineral density in adolescent females using injectable or oral contraceptives: a 24-month prospective study

Fertility and Sterility

Volumn 90, Issue 6, 2008, Pages 2060-2067

  Cromer, Barbara A ^a   Bonny, Andrea E ^a   Stager, Margaret ^a   Lazebnik, Rina ^b   Rome, Ellen ^c   Ziegler, Julie ^a   Camlin Shingler, Kelly ^a   Secic, Michelle ^d  

^a METROHEALTH MEDICAL CENTER   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d Secic Statistical Consulting Inc   (United States)

Author keywords

Adolescents; bone mineral density; depot medroxyprogesterone acetate; oral contraceptives

Indexed keywords

ETHINYLESTRADIOL; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; BONE DENSITY; BONE MINERAL; CONTROLLED STUDY; DRUG ACTIVITY; FEMALE; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; OSTEOLYSIS; PRIORITY JOURNAL;

ABSORPTIOMETRY, PHOTON; ADOLESCENT; BONE DENSITY; CHILD; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVES, ORAL, COMBINED; CONTRACEPTIVES, ORAL, HORMONAL; DELAYED-ACTION PREPARATIONS; ETHINYL ESTRADIOL; FEMALE; FEMUR NECK; HUMANS; INJECTIONS, INTRAMUSCULAR; LEVONORGESTREL; LUMBAR VERTEBRAE; MEDROXYPROGESTERONE 17-ACETATE; MIDWESTERN UNITED STATES; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 53449096072     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.10.070     Document Type: Article

References (25)

1. Sabatier J.P., Guaydier-Souquieres G., Benmalek A., and Marcelli C. Evolution of bone mineral content during adolescence and adulthood: a longitudinal study in 295 healthy females 10-24 years of age and 206 premenopausal women. Osteoporos Int 9 (1999) 476-482
2. Cromer B.A., Blair J.M., Mahan J.D., Zibners L., and Naumovski Z. A prospective comparison of bone density in adolescent girls on depot medroxyprogesterone acetate (Depo-Provera), Levonorgestrel (Norplant), or oral contraceptives. J Pediatr 129 (1996) 671-676
3. Cromer B.A., Stager M., Bonny A., Lazebnik R., Rome E., and Debanne S. Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls. J Adolesc Health 35 (2004) 434-441
4. US Food and Drug Administration. FDA talk paper. Black box warning added concerning long-term use of Depo-Provera contraceptive injection. November 17, 2004. Available at: http://www.fda.gov/bbs/topics/ANSWERS/2004/ANS01325.html.
5. Westhoff C. Trends in oral contraceptive development and utilization: looking to the future. Contracept Rep 7 (1997) 4-13
6. Carr B.R., and Ory H. Estrogen components of oral contraceptives: relationship to vascular disease. Contraception 55 (1997) 267-272
7. Hertzler A.A., and Trary R.B. A dietary calcium rapid assessment method (RAM). Innovations in practice: a dietary calcium RAM. Top Clin Nutr 9 (1994) 76-85
8. Katzman D.K., Bachrach L.K., Carter D.R., and Marcus R. Clinical and anthropometric correlations of bone mineral acquisition in healthy adolescent girls. J Clin Endocrinol Metab 73 (1991) 1332-1339
9. Cromer B.A., Blair J.M., Mahan J.D., Zibners L., and Naumowkski Z. A prospective comparison of bone density in adolescent girls on depot medroxyprogesterone acetate (Depo-Provera), Levonorgestrel (Norplant), or oral contraceptives. J Pediatr 129 (1996) 671-676
10. Busen N.H., Britt R.B., and Rianon N. Bone mineral density in a cohort of adolescent women using depot medroxyprogesterone acetate for one to two years. J Adolesc Health 32 (2003) 257-259
11. Cromer B.A., Stager M., Bonny A., Lazebnik R., Rome E., Ziegler J., et al. Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls. J Adolesc Health 35 (2004) 434-441
12. Lara-Torre E., Edwards C.P., Perlman S., and Hertweck S.P. Bone mineral density in adolescent females using depomedroxyprogesterone acetate. J Pediatr Adolesc Gynecol 17 (2004) 17-21
13. Scholes D., LaCroix A.Z., Ichikawa L.E., Barlow W.E., and Ott S.M. Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone contraception. Arch Pediatr Adolesc Med 159 (2005) 139-144
14. Davies M.C., Hall M.C., and Jacobs H.S. Bone mineral loss in young women with amenorrhea. Br Med J 301 (1990) 790-793
15. Orr-Walker B.J., Evans M.C., Ames R.W., Clearwater J.M., Cundy T., and Reid I.R. The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal post-menopausal women. Clin Endocrinol 49 (1998) 615-618
16. Petitti D.B., Piaggio G., Mehta S., Cravioto M.C., and Meirik O. Steroid hormone contraception and bone mineral density: a cross-sectional study in an international population. Obstet Gynecol 95 (2000) 736-744
17. Nelson A. Merits of DMPA relative to other reversible contraceptive methods. J Reprod Med 47 (2002) 781-784
18. Cromer B. Hormonal contraception and bone mineral density; unique issues in adolescent and young adult women. Clin Rev Bone Miner Metab 2 (2004) 123-134
19. Sowers M.R., Scholl T., Harris L., and Jannausch M. Bone loss in adolescent women and adult pregnant women. Obstet Gynecol 96 (2000) 189-193
20. Harville E.W., Schramm M., Watt-Morse M., Chantala K., Anderson J.J., and Hertz-Picciotto I. Calcium intake during pregnancy among white and African-American pregnant women in the United States. J Am Coll Nutr 23 (2004) 43-50
21. Cundy T., Cornish J., Evans M.C., Roberts H., and Reid I.R. Recovery of bone density in women who stop using medroxyprogesterone acetate. BMJ 308 (1994) 247-248
22. Cromer B.A., Scholes D., Berenson A., Cundy T., Clark M.K., and Kaunitz A.M. Depot medroxyprogesterone acetate and bone mineral density in adolescents-the Black Box Warning: a Position Paper of the Society for Adolescent Medicine. J Adolesc Health 39 (2006) 296-301
23. American College of Obstetricians and Gynecologists, Women's Health Care Physicians. ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. No. 50, January 2003. Obstet Gynecol 103 (2004) 203-216
24. World Health Organization. Statement on hormonal contraception and bone health. Special Program of Research, Development and Training in Human Reproduction. July 2005. Available at: http://www.who.int/reproductive-health/family_planning/bone_health.html.
25. Polatti F., Perotti F., Filippa N., Gallina D., and Nappi R.E. Bone mass and long-term monophasic oral contraceptive treatment in young women. Contraception 51 (1995) 221-224